Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy
Combination therapy: sensitizing platinum-resistant tumors Carboplatin efficacy can be restored by administering it with birinapant, a drug combination that targets platinum-resistant cancer cells. Platinum-based chemotherapeutics are used to treat almost 50% of cancer patients. Despite excellent in...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Nature Portfolio
2017
|
| Subjects: | |
| Online Access: | https://doaj.org/article/7a7a5d26d3d140b79e1df58bdb310f23 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|